Does RISANKIZUMAB-RZAA Cause Dermatitis atopic? 28 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Dermatitis atopic have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
28
Reports of Dermatitis atopic with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
1
Deaths
4
Hospitalizations
How Dangerous Is Dermatitis atopic From RISANKIZUMAB-RZAA?
Of the 28 reports, 1 (3.6%) resulted in death, 4 (14.3%) required hospitalization.
Is Dermatitis atopic Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Dermatitis atopic?
DUPILUMAB (33,670)
TRALOKINUMAB-LDRM (613)
UPADACITINIB (525)
RUXOLITINIB (211)
TACROLIMUS (200)
CRISABOROLE (134)
NEMOLIZUMAB-ILTO (117)
OMALIZUMAB (111)
ABROCITINIB (110)
PREDNISONE (105)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Dermatitis atopic Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA